Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Global Genetic Engineering Market By Product type, By Technique By End User and Region Forecast 2019-2030
Global Genetic Engineering Market By Product type, By Technique By End User and Region Forecast 2019-2030
Genetic Engineering Market size was valued at US$ 6.8 billion in 2023 and is poised to grow at a significant CAGR of 15.5% from 2024-2030. The alteration of genes in an organism or species to improve its skills is known as genetic engineering. Pharmaceutical and biotechnology firms, as well as clinical research institutions, utilize the technology. Gene therapy is the most extensively utilized therapeutic method for cancer and other infectious disorders in medicine. The market includes the set of technologies that directly manipulate an organism's genes, change the genetic makeup of cells, and add one or more new traits that are not found in that organism. At the core of all life is the thing that we call DNA. It is in charge of the plenitude of life on this Earth and the motivation behind why we are how we are. The hereditary makeup of any creature is characterized by DNA.
In nature, the genetic nature never stays settled. Biotech and pharma sectors dominate the industry owing to several applications in drug discovery and therapeutics. With the increase in the use of CRISPR and ZFN, companies are capitalizing on innovative research focusing on the development of editing techniques. For example, the introduction of an initiative called the Artemisinin Project is planning to use synthetic biology to help treat malaria. Key strategies implemented by industry players include mergers and acquisitions, and strategic collaborations for R&D outsourcing or manufacturing activities are driving the market growth of genome editing.
Study Period
2024-2030Base Year
2023CAGR
15.55%Largest Market
North AmericaFastest Growing Market
Asia-Pacific
Increasing prevalence of cancer and other genetic disorders, growing preference for personalized medicine, Increase in R&D expenditure and growth of biotechnology and pharmaceutical industries, increase in private and public sector funding, rapid advancements in sequencing and genetic engineering technologies, applications in various drug discovery processes are some of the factors propelling the growth of the market. Moreover, the market may be hindered by stringent government regulations for approval to gene mutation projects, ethical issues, unavailability of gene based therapeutics in the market and lack of awareness among people regarding the safety of genetic interventions.
The market is dominated by North America due to the strong growth trend in the pharmaceuticals and biotechnology industries and is followed by Europe. Emerging economies of Asia Pacific and Latin America are expected to show significant growth in the market due to an increase in the number of laboratories in these regions and development of existing ones for automation of various instrumentation systems, the expansion of leading genetic engineering companies and increased R&D spending.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 6.8 billion |
|
Market CAGR |
15.55% |
|
By Type |
|
|
By Technique |
|
|
By End User |
|
|
By Region |
|
Download Free Sample Report
The global genetic engineering market size was valued at US$ 6.8 billion in 2023 and is projected to grow at a CAGR of 15.55% from 2024 to 2030.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
The genetic engineering market key palyers are Thermo Fisher Scientific Inc, Merck KGaA, Horizon Discovery Group Plc., Transposagen Biopharmaceuticals Inc, Genentech, Inc.
| 1.Executive Summary |
| 2.Global Genetic Engineering Market Introduction |
| 2.1.Global Genetic Engineering Market - Taxonomy |
| 2.2.Global Genetic Engineering Market - Definitions |
| 2.2.1.Type |
| 2.2.2.Technique |
| 2.2.3.End User |
| 2.2.4.Region |
| 3.Global Genetic Engineering Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Genetic Engineering Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Genetic Engineering Market By Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Cell Line |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Animal Genome |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Plant Genome |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6.Global Genetic Engineering Market By Technique, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Artificial Selection |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Cloning |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Gene Splicing |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Others |
| 6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 7.Global Genetic Engineering Market By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. Pharmaceutical companies |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Biotechnology Companies |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Academics |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Clinical Research Organizations |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 8.Global Genetic Engineering Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.North America Genetic Engineering Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Cell Line |
| 9.1.2.Animal Genome |
| 9.1.3.Plant Genome |
| 9.2. Technique Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Artificial Selection |
| 9.2.2.Cloning |
| 9.2.3.Gene Splicing |
| 9.2.4.Others |
| 9.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Pharmaceutical companies |
| 9.3.2.Biotechnology Companies |
| 9.3.3.Academics |
| 9.3.4.Clinical Research Organizations |
| 9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10.Europe Genetic Engineering Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Cell Line |
| 10.1.2.Animal Genome |
| 10.1.3.Plant Genome |
| 10.2. Technique Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Artificial Selection |
| 10.2.2.Cloning |
| 10.2.3.Gene Splicing |
| 10.2.4.Others |
| 10.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Pharmaceutical companies |
| 10.3.2.Biotechnology Companies |
| 10.3.3.Academics |
| 10.3.4.Clinical Research Organizations |
| 10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 10.4.6.Rest of EU |
| 11.Asia Pacific (APAC) Genetic Engineering Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Cell Line |
| 11.1.2.Animal Genome |
| 11.1.3.Plant Genome |
| 11.2. Technique Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Artificial Selection |
| 11.2.2.Cloning |
| 11.2.3.Gene Splicing |
| 11.2.4.Others |
| 11.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Pharmaceutical companies |
| 11.3.2.Biotechnology Companies |
| 11.3.3.Academics |
| 11.3.4.Clinical Research Organizations |
| 11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12.Middle East and Africa (MEA) Genetic Engineering Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Cell Line |
| 12.1.2.Animal Genome |
| 12.1.3.Plant Genome |
| 12.2. Technique Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Artificial Selection |
| 12.2.2.Cloning |
| 12.2.3.Gene Splicing |
| 12.2.4.Others |
| 12.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Pharmaceutical companies |
| 12.3.2.Biotechnology Companies |
| 12.3.3.Academics |
| 12.3.4.Clinical Research Organizations |
| 12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13.Latin America Genetic Engineering Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 13.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Cell Line |
| 13.1.2.Animal Genome |
| 13.1.3.Plant Genome |
| 13.2. Technique Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Artificial Selection |
| 13.2.2.Cloning |
| 13.2.3.Gene Splicing |
| 13.2.4.Others |
| 13.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Pharmaceutical companies |
| 13.3.2.Biotechnology Companies |
| 13.3.3.Academics |
| 13.3.4.Clinical Research Organizations |
| 13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Thermo Fisher Scientific Inc. (US) |
| 14.2.2.Merck KGaA (Germany) |
| 14.2.3.Horizon Discovery Group Plc. (UK) |
| 14.2.4.Transposagen Biopharmaceuticals Inc. (US) |
| 14.2.5.New England Biolabs (U.S) |
| 14.2.6.Genscript Biotech Corporation (US) |
| 14.2.7.Lonza Group Ltd. (Switzerland) |
| 14.2.8.Origene Technologies, Inc. (US) |
| 14.2.9.Integrated DNA Technologies, Inc. (US) |
| 14.2.10.Amgen Inc.(US) |
| 14.2.11.Genentech, Inc. (US) |
| 14.2.12.Sangamo Therapeutics, Inc. (US) |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.